| Log in

Par Pharmaceutical buys Ethics Bio Lab for around $20M

21 January, 2015

NYSE-listed Par Pharmaceutical, Inc has acquired Ethics Bio Lab Pvt Ltd, a Chennai-based contract research organisation (CRO) in an all cash transaction for around $20 million (Rs ....

To read the Full Story

Definitive news, exclusives, analyses and videos

  • Exclusive reporting, expert analysis and commentary on PE/VC/M&A deals & dealmakers
  • Daily, weekly and monthly curated newsletters on the deal ecosystem in India
  • Breaking news alerts
  • Participation in marquee events at concessional rates

Comprehensive | Accurate | Unbiased | Impeccably sourced


Leave Your Comment
US-Based Par Pharma Acquires Indian Pharma Co Edict for $37M

US-Based Par Pharma Acquires Indian Pharma Co Edict for $37M

TEAM VCC 6 years ago
NYSE-listed Par Pharmaceutical Companies Inc. is acquiring privately held Edict...
Sun Pharma CEO Picks 11.26% In Israeli Investment Co Bio-Light

Sun Pharma CEO Picks 11.26% In Israeli Investment Co Bio-Light

Anil Das 6 years ago
Mumbai-based Sun Pharmaceutical’s chief executive officer Dilip Shanghvi will...
Pfizer, Teva Pharma & PE Firms Eye Micro Labs Buyout

Pfizer, Teva Pharma & PE Firms Eye Micro Labs Buyout

Shrija Agrawal 6 years ago
After Ranbaxy Labs and Piramal Healthcare, another billion-dollar-plus deal...
No Comments

Par Pharmaceutical buys Ethics Bio Lab for around $20M

Powered by WordPress.com VIP